Panacea Biotec Wins ₹78.24 Cr UNICEF Award for Bivalent Oral Polio Vaccine Supply

has received a Letter of Award from UNICEF for the supply of bivalent oral polio vaccine (bOPV) in 10 and 20 dose presentations. The order is valued at ₹78.24 crore. This contract strengthens the company’s position as a key supplier of WHO-prequalified vaccines to global immunization programmes and adds to its existing long-term agreements with UNICEF for polio vaccine supplies. *Top stocks in the pharmaceuticals / vaccines industry:* Biocon, Zydus Lifesciences, and Hester Biosciences.